Supplementary Table S2 from Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor–Resistant EGFR-Mutant Lung Cancer with and without T790M Mutations
Open Access
- 3 April 2023
- other
- Published by American Association for Cancer Research (AACR)